1. Market Research
  2. > Pathology
37 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Auto-Injectors Market (By Application/Indication, Product Type, Usability, Distribution Channels, Region), Key Company Profiles - Forecast to 2025

  • $ 1990
  • August 2019
  • 126 pages

lymphoma, OCREVUS for the treatment of primary progressive MS (PPMS) and relapsing MS (RMS) and other potential anti-CD## therapies pursuant to its collaboration arrangements with Genentech, Inc.

  • Injectable Delivery
  • Lymphoma
  • World
  • Amgen Inc.
  • Antares Pharma, Inc.

Global Autoimmune Disease Diagnostic Market (By Disease, Tests Type, Regions), Key Company Profiles - Forecast to 2026

  • $ 1890
  • November 2019
  • 137 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases.

  • Autoimmune Disease
  • Diagnostics
  • Lymphoma
  • Pathology
  • World

Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025

  • $ 1690
  • December 2019
  • 218 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases.

  • Diagnostics
  • Laboratory
  • Lymphoma
  • Point Of Care Testing
  • World

Proton Therapy Market Outlook, Actual & Potential Market, Actual and Potential Candidate for Proton Therapy, List of Proton Therapy Centers, Start of Treatment, Number of Patients Treated, Specifications & Company Analysis - Global Forecast to 2024

  • $ 2390
  • July 2018
  • 429 pages

The patient population will consist of pediatrics, adolescents, and young adults with cancers, such as Brain Tumors, Rhabdomyosarcomas, and Lymphomas.

  • Hospital
  • Lymphoma
  • Specialty Hospital
  • Forecast
  • Market Size

United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025

  • $ 1990
  • September 2019
  • 201 pages

In the clinical domain, flow cytometers are used mainly to diagnose leukemia, malignant lymphoma and other blood diseases, as well as to monitor immune function and to consider treatment methods for HIV patients.

  • Diagnostics
  • In Vitro Diagnostics
  • Lymphoma
  • North America
  • United States

Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026

  • $ 2490
  • January 2019
  • 360 pages

It provides clinical products, such as FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and sarcomas; Foundation Assay for Circulating Tumor; FoundationFocus CDxBRCA, a diagnostic assay to aid in identifyi

  • Biotech Diagnostics
  • Cancer
  • Genetic Testing
  • Genomics
  • Lymphoma

Japan IVD Market Size, Share, Major Deals & Company Analysis – Forecast to 2025

  • $ 1990
  • February 2019
  • 128 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases.

  • In Vitro Diagnostics
  • Laboratory
  • Lymphoma
  • East Asia
  • Japan

Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Forecast to 2025

  • $ 2190
  • March 2018
  • 305 pages

It provides clinical products, such as FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and myeloma, as wel as sarcomas and pediatric cancers; Foundation Assay for Circulating Tumor; FoundationFocus CDxBRC

  • Biotech Diagnostics
  • Cancer
  • Genetic Testing
  • Genomics
  • Lymphoma

Global Biopsy Device Market, Biopsy Procedure Volume, Company Product Analysis and Forecast To 2022

  • $ 1600
  • January 2018
  • 240 pages

This may be particularly true with trying to make a diagnosis of lymphoma.

  • Biopsy
  • Diagnostics
  • Injectable Delivery
  • Lymphoma
  • World

Global Proton Therapy Market (28 Countries Analysis), Patients Treated, List of Proton Therapy Centers, Start of Treatment, Specifications & Company Analysis

  • $ 1950
  • July 2017
  • 411 pages

THE PATIENT POPULATION WILL CONSIST OF PEDIATRICS, ADOLESCENTS, AND YOUNG ADULTS WITH CANCERS, SUCH AS BRAIN TUMORS, RHABDOMYOSARCOMAS, AND LYMPHOMAS.

  • Hospital
  • Lymphoma
  • Specialty Hospital
  • Forecast
  • Market Size

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • $ 1350
  • October 2016
  • 177 pages

Common blood disorders include anemia, bleeding disorders such as hemophilia, blood clots, and blood cancers such as leukemia, lymphoma and myeloma.

  • Biopharmaceutical
  • Biosimilar
  • Lymphoma
  • Medical Biotechnology
  • Pharmaceutical

Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers, Start of Treatment, Specifications & Company Analysis - Global Forecast to 2022

  • $ 2190
  • May 2017
  • 411 pages

THE PATIENT POPULATION WILL CONSIST OF PEDIATRICS, ADOLESCENTS, AND YOUNG ADULTS WITH CANCERS, SUCH AS BRAIN TUMORS, RHABDOMYOSARCOMAS, AND LYMPHOMAS.

  • Hospital
  • Lymphoma
  • Specialty Hospital
  • Forecast
  • Market Size

Blood Glucose (SMBG) (Test Strips, Lancet, Meter) Market and Forecast - Global Analysis

  • $ 1690
  • March 2017
  • 376 pages

lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and west nile virus diseases.

  • Diabetes
  • Diabetes Monitoring
  • Lymphoma
  • Patient Monitoring
  • Forecast

Biopsy Device Market (By Country Wise and Product Segment) and Biopsy Procedure Volume Forecast To 2020 - Global Analysis

  • $ 1400
  • January 2017
  • 233 pages

This may be particularly true with trying to make a diagnosis of lymphoma.

  • Biopsy
  • Diagnostics
  • Injectable Delivery
  • Lymphoma
  • World

Switzerland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

  • $ 1050
  • May 2017
  • 51 pages

The patient population will consist of pediatrics, adolescents, and young adults with cancers, such as Brain Tumors, Rhabdomyosarcomas, and Lymphomas.

  • Cancer
  • Diagnostic Imaging
  • Lymphoma
  • Specialty Hospital
  • Switzerland

Europe Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

  • $ 1790
  • May 2017
  • 212 pages

The patient population will consist of pediatrics, adolescents, and young adults with cancers, such as Brain Tumors, Rhabdomyosarcomas, and Lymphomas.

  • Cancer
  • Lymphoma
  • Forecast
  • Market Size
  • Varian Medical Systems, Inc.

Asia Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022

  • $ 1450
  • May 2017
  • 133 pages

The patient population will consist of pediatrics, adolescents, and young adults with cancers, such as Brain Tumors, Rhabdomyosarcomas, and Lymphomas.

  • Lymphoma
  • Specialty Hospital
  • East Asia
  • Hitachi, Ltd.
  • Mitsubishi Corporation

Global Proton Therapy Market (Actual and Potential) and Centers Analysis

  • $ 1490
  • June 2016
  • 163 pages

The patient population will consist of pediatrics, adolescents, and young adults with cancers, such as Brain Tumors, Rhabdomyosarcomas, and Lymphomas.

  • Lymphoma
  • Specialty Hospital
  • Hitachi, Ltd.
  • Mitsubishi Corporation
  • Varian Medical Systems, Inc.

Molecular Diagnostics Market (By Application, Technology, Region and Companies) and Forecast to 2021 - Global Analysis

  • $ 1100
  • September 2016
  • 149 pages

lymphomas CMD, oral CMD, and others.

  • Biotech Diagnostics
  • Infectious Disease
  • Lymphoma
  • Molecular Diagnostics
  • bioMerieux S.A.
View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Lymphoma Statistics December 2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on